![TCRCure Biopharma](https://otc.duke.edu/wp-content/uploads/2022/09/TCRCure-Biopharma.jpeg)
TCRCure Biopharma
TCRCure Biopharma Ltd. aims to develop next-generation cancer immunotherapies that control tumor progression, convert cancers to manageable chronic diseases, and eventually lead to a cure.TCRCure is a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry scale virus production, T cell genetic engineering, and immune cell manufacturing.